EOM Pharmaceutical Holdings Inc (IMUC)
0.1840
+0.03
(+18.68%)
USD |
OTCM |
May 03, 16:00
EOM Pharmaceutical Holdings Cash from Operations (Quarterly): -2.174M for June 30, 2018
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2018 | -2.174M |
| March 31, 2018 | -1.603M |
| December 31, 2017 | -4.929M |
| September 30, 2017 | -2.220M |
| June 30, 2017 | -3.453M |
| March 31, 2017 | -6.070M |
| December 31, 2016 | -3.741M |
| September 30, 2016 | -4.929M |
| June 30, 2016 | -5.843M |
| March 31, 2016 | -5.351M |
| December 31, 2015 | -5.816M |
| September 30, 2015 | -6.316M |
| June 30, 2015 | -3.858M |
| March 31, 2015 | -3.049M |
| December 31, 2014 | -2.109M |
| September 30, 2014 | -2.512M |
| June 30, 2014 | -2.703M |
| March 31, 2014 | -2.614M |
| December 31, 2013 | -2.733M |
| September 30, 2013 | -1.937M |
| June 30, 2013 | -1.910M |
| March 31, 2013 | -2.207M |
| December 31, 2012 | -3.192M |
| September 30, 2012 | -2.298M |
| June 30, 2012 | -3.311M |
| Date | Value |
|---|---|
| March 31, 2012 | -3.579M |
| December 31, 2011 | -1.785M |
| September 30, 2011 | -1.789M |
| June 30, 2011 | -1.275M |
| March 31, 2011 | -1.535M |
| December 31, 2010 | -0.9414M |
| September 30, 2010 | -1.501M |
| June 30, 2010 | -1.134M |
| March 31, 2010 | -0.6771M |
| December 31, 2009 | -0.2685M |
| September 30, 2009 | -0.583M |
| June 30, 2009 | -0.7741M |
| March 31, 2009 | -0.5262M |
| December 31, 2008 | -0.4228M |
| September 30, 2008 | -0.4528M |
| June 30, 2008 | -0.4788M |
| March 31, 2008 | -0.5911M |
| December 31, 2007 | -0.3246M |
| September 30, 2007 | -0.0798M |
| June 30, 2007 | -0.2493M |
| March 31, 2007 | -0.2584M |
| December 31, 2006 | -0.2781M |
| September 30, 2006 | -0.0253M |
| June 30, 2006 | -0.0978M |
| March 31, 2006 | -0.1265M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| CEL-SCI Corp | -4.888M |
| AIM ImmunoTech Inc | -9.758M |
| IGC Pharma Inc | -1.587M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Protalix BioTherapeutics Inc | 3.595M |